Ayala Pharmaceuticals Bruttomarge
Was ist das Bruttomarge von Ayala Pharmaceuticals?
Bruttomarge von Ayala Pharmaceuticals Inc. ist 100.00%
Was ist die Definition von Bruttomarge?
Die Bruttomarge ist die Differenz zwischen Umsatz und Kosten der verkauften Waren, dividiert durch den Umsatz und in Prozent ausgedrückt.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttomarge von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Ayala Pharmaceuticals
Was macht Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Unternehmen mit bruttomarge ähnlich Ayala Pharmaceuticals
- Zenkoku Hosho Co hat Bruttomarge von 99.99%
- Damartex SA hat Bruttomarge von 100.00%
- Consolidated Finvest & hat Bruttomarge von 100.00%
- McDowell hat Bruttomarge von 100.00%
- Vanguard Specialized Funds - Vanguard Real Estate ETF hat Bruttomarge von 100.00%
- BlackRock MuniVest Fund hat Bruttomarge von 100.00%
- Ayala Pharmaceuticals hat Bruttomarge von 100.00%
- CRCAM Loire Haute-Loire hat Bruttomarge von 100.00%
- iShares Trust - iShares Core S&P 500 ETF hat Bruttomarge von 100.00%
- Clean Power Capital hat Bruttomarge von 100.00%
- Investec plc hat Bruttomarge von 100.00%
- Atlas Mara hat Bruttomarge von 100.00%
- Huarong International hat Bruttomarge von 100.00%